Get started
CHINA M.SYS.H.CONS.DL-005CHINA M.SYS.H.CONS.DL-005CHINA M.SYS.H.CONS.DL-005

CHINA M.SYS.H.CONS.DL-005

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

2M7C chart


Full chart

2M7C upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪2.40 B‬ EUR
Dividend yield (indicated)
3.34%
Price to earnings Ratio (TTM)
11.965
Basic EPS (TTM)
0.090 EUR
Net income (FY)
‪218.30 M‬ EUR
Revenue (FY)
‪1.01 B‬ EUR
Shares float
‪1.18 B‬
Beta (1Y)
0.83

Employees


Employees (FY)
‪6.14 K‬
Change (1Y)
+440 +7.72%
Revenue / Employee (1Y)
‪163.92 K‬ EUR
Net income / Employee (1Y)
‪35.55 K‬ EUR

About CHINA MEDICAL SYSTEM HLDGS LTD


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Kong Lam
Website
cms.net.cn
Headquarters
Shenzhen
Founded
1995
FIGI
BBG00162N910
China Medical System Holdings Ltd. engages in the production, marketing, promotion, and sale of drugs. Its products include Plendil, Ursofalk, Deanxit, Xinhuosu, Salofalk, BIOFLOR, Augentropfen Stulln Mono, Hirudoid, Combizym, Tanshinone Capsules, Yinuoshu, Nuodikang Capsules, Xidakang, Ganfule Capsules, Imdur, Parlodel, Elcitonin, Lamisil, Yinlian Qinggan Granules, MOVICOL. The company was founded by Kong Lam in January 1995 and is headquartered in Shenzhen, China.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

2M7C news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as 2M7C.

Frequently Asked Questions


The current price of 2M7C is 0.950 EUR — it has decreased by −3.08% in the past 24 hours. Watch CHINA M.SYS.H.CONS.DL-005 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange CHINA M.SYS.H.CONS.DL-005 stocks are traded under the ticker 2M7C.
2M7C stock has risen by 16.67% compared to the previous week, the month change is a 8.00% rise, over the last year CHINA M.SYS.H.CONS.DL-005 has showed a 18.75% increase.
We've gathered analysts' opinions on CHINA M.SYS.H.CONS.DL-005 future price: according to them, 2M7C price has a max estimate of 1.41 EUR and a min estimate of 1.05 EUR. Watch 2M7C chart and read a more detailed CHINA M.SYS.H.CONS.DL-005 stock forecast: see what analysts think of CHINA M.SYS.H.CONS.DL-005 and suggest that you do with its stocks.
2M7C reached its all-time high on Jul 7, 2008 with the price of 80.790 EUR, and its all-time low was 0.325 EUR and was reached on Jun 18, 2012. View more price dynamics on 2M7C chart.
See other stocks reaching their highest and lowest prices.
2M7C stock is 2.63% volatile and has beta coefficient of 0.83. Track CHINA M.SYS.H.CONS.DL-005 stock price on the chart and check out the list of the most volatile stocks — is CHINA M.SYS.H.CONS.DL-005 there?
Today CHINA M.SYS.H.CONS.DL-005 has the market capitalization of ‪2.38 B‬, it has increased by 1.26% over the last week.
Yes, you can track CHINA M.SYS.H.CONS.DL-005 financials in yearly and quarterly reports right on TradingView.
CHINA M.SYS.H.CONS.DL-005 is going to release the next earnings report on Aug 14, 2025. Keep track of upcoming events with our Earnings Calendar.
2M7C earnings for the last half-year are 0.038 EUR per share, whereas the estimation was 0.045 EUR, resulting in a −14.71% surprise. The estimated earnings for the next half-year are 0.041 EUR per share. See more details about CHINA M.SYS.H.CONS.DL-005 earnings.
CHINA M.SYS.H.CONS.DL-005 revenue for the last half-year amounts to ‪510.41 M‬ EUR, despite the estimated figure of ‪537.91 M‬ EUR. In the next half-year revenue is expected to reach ‪477.83 M‬ EUR.
2M7C net income for the last half-year is ‪95.65 M‬ EUR, while the previous report showed ‪117.92 M‬ EUR of net income which accounts for −18.88% change. Track more CHINA M.SYS.H.CONS.DL-005 financial stats to get the full picture.
CHINA M.SYS.H.CONS.DL-005 dividend yield was 3.85% in 2024, and payout ratio reached 40.22%. The year before the numbers were 3.09% and 39.56% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 25, 2025, the company has ‪6.14 K‬ employees. See our rating of the largest employees — is CHINA M.SYS.H.CONS.DL-005 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CHINA M.SYS.H.CONS.DL-005 EBITDA is ‪257.37 M‬ EUR, and current EBITDA margin is 25.58%. See more stats in CHINA M.SYS.H.CONS.DL-005 financial statements.
Like other stocks, 2M7C shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHINA M.SYS.H.CONS.DL-005 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CHINA M.SYS.H.CONS.DL-005 technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CHINA M.SYS.H.CONS.DL-005 stock shows the sell signal. See more of CHINA M.SYS.H.CONS.DL-005 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.